NCT02218320View on ClinicalTrials.gov

Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Human Immunodeficiency Virus
Interventions
DRUG

Raltegravir

DRUG

Dolutegravir

PROCEDURE

Colonoscopy with biopsy

This procedure is not standard of care for patients receiving combination antiretroviral therapy (cART), but is necessary to obtain tissue samples.

Trial Locations (1)

27599

Clinical and Translational Research Center, UNC Hospitals, Chapel Hill

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT02218320 - Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults | Biotech Hunter | Biotech Hunter